NEWS CORPORATION (NWSA) valuation

Share price $26.20 · Close 2026-04-24

Price-to-Earnings

P/E · Trailing Diluted
12.91×
P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing
26.15×
P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing
3.82%
FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing
EV/EBITDA history →

Price-to-Sales

P/S · Trailing
1.71×
P/S history →

Price-to-Book

P/B · Latest filing
1.67×
P/B history →

Expectations investing: what does the price imply?

Stress figure — scenario margin 80% above 3-yr max 11%

Rappaport-style reverse-DCF. We start from the current market price ($26.20 × 562.0M shares = $14.72B market cap, $15.60B enterprise value) and solve for the operating path that would justify it.

To reconcile today's price with a plausible scenario, the model lands on:

  • Year-1 revenue growth: 16.1%
    Source is analyst consensus (absolute forecast, TTM-anchored) of 2.1%; the scenario bumped Y1 by +14.0pp and still needed the margin band widened — both levers are at stretch.
  • Target EBIT margin (Y10): 80.0%
    Scenario lands on 80.0%, above the historical band (3-yr range 4.7%–10.9%). The reconciliation needs a margin the filer has not shown.
  • High-growth plateau: 3 years
    Tier default for Y2 at 4.0%.

at or below the reference above the reference outside the historical band

Where the PV comes from
Y1–3
-145%
Y4–10
-199%
Terminal
+444%

Share of the total PV the model has assigned to each window. The further out a cash flow sits, the harder it is to estimate — so readers can weigh how much of the scenario rests on the near, plateau, and post-horizon periods.

Facts · TTM as of 2025-12-31 (Q22026)

Share price
$26.20
Diluted shares
562.0M
Total debt
$2.92B
Cash & equivalents
$2.05B
Revenue
$8.62B
Pretax income (cont. ops)
$862.0M
Filer does not tag us-gaap:OperatingIncomeLoss; using pretax income from continuing operations as the operating-income base. For banks this is effectively operating income (interest expense is a core cost); for oil majors and some pharma filers it's a close proxy with small non-operating items mixed in.
Pretax margin
10.0%
Operating cash flow
CapEx
$430.0M
Observed YoY growth
2.4%
Analyst current-FY growth
4.2%
Analyst next-FY growth
4.0%
3-year revenue CAGR
-6.0%

Assumptions

Initial revenue growth
2.1%
from analyst consensus (absolute forecast, TTM-anchored)
(analyst FY-over-FY consensus: 4.2% — shown effective rate normalises it against our TTM base, which spans the current FY partway)
Year-2 growth
4.0%
from analyst next-FY consensus
Starting EBIT margin
10.0%
from latest FY EBIT margin (GAAP)
Tax rate
35.2%
from 3-year median of EffectiveTaxRate
Starting ROIC
5.8%
NOPAT₀ ÷ invested capital, capped at 40.0%

Constants

Horizon
10 years
WACC
9.0%
Terminal growth
2.5%
Terminal ROIC
11.0%

Yearly projection

Year Revenue Growth EBIT Margin NOPAT ROIC Reinvestment FCF Discount PV of FCF
1 $10.02B 16.1% $1.70B 17.0% $1.10B 6.3% $8.64B -$7.54B 0.917 -$6.91B
2 $11.82B 18.0% $2.84B 24.0% $1.84B 6.8% $10.77B -$8.93B 0.842 -$7.52B
3 $13.95B 18.0% $4.32B 31.0% $2.80B 7.3% $13.12B -$10.31B 0.772 -$7.96B
4 $16.15B 15.8% $6.14B 38.0% $3.98B 7.9% $14.93B -$10.96B 0.708 -$7.76B
5 $18.34B 13.6% $8.25B 45.0% $5.35B 8.4% $16.35B -$11.00B 0.650 -$7.15B
6 $20.42B 11.4% $10.62B 52.0% $6.88B 8.9% $17.21B -$10.33B 0.596 -$6.16B
7 $22.29B 9.1% $13.15B 59.0% $8.52B 9.4% $17.39B -$8.87B 0.547 -$4.85B
8 $23.84B 6.9% $15.73B 66.0% $10.19B 10.0% $16.79B -$6.60B 0.502 -$3.31B
9 $24.96B 4.7% $18.22B 73.0% $11.80B 10.5% $15.39B -$3.59B 0.460 -$1.65B
10 $25.58B 2.5% $20.47B 80.0% $13.26B 11.0% $13.23B $28.7M 0.422 $12.1M
Sum of PV of FCF (years 1-10) -$53.26B

Terminal value

NOPATN+1
$13.59B
ReinvestmentN+1
$3.01B
FCFN+1
$10.58B
Terminal value (undiscounted)
$162.74B
PV of terminal value
$68.74B
Gordon-growth: TV = FCFN+1 ÷ (WACC − g) = $10.58B ÷ (9.0% − 2.5%).

Equity bridge

PV of operating FCF -$53.26B
+ PV of terminal value $68.74B
= Enterprise value $15.48B
− Total debt $2.92B
+ Cash & equivalents $2.05B
= Equity value $14.61B
÷ Diluted shares 562.0M
= DCF PV / share $25.99
Market price $26.20
Reconciliation delta −0.8% (widened band)
Full calculation trail Click to expand — every number on this page derived step by step.

0 · TTM reconstruction (anchor: Q22026, 2025-12-31)

The latest filing is a 10-Q, so "base year" revenue / EBIT / OCF / CapEx are reconstructed as trailing-twelve-month values. Per-quarter facts (typical for income-statement items) get summed across four quarters; YTD-cumulative facts (typical for cash-flow items) use prior FY + YTDnow − YTDprior year same quarter.

Revenue
Sum of the four most recent per-quarter values
  • Q2 FY26 (2025-12-31): $2.36B
  • Q1 FY26 (2025-09-30): $2.14B
  • Q4 FY25 (2025-06-30): $2.11B
  • Q3 FY25 (2025-03-31): $2.01B
  • = $8.62B
EBIT
Sum of the four most recent per-quarter values
  • Q2 FY26 (2025-12-31): $367.0M
  • Q1 FY26 (2025-09-30): $212.0M
  • Q4 FY25 (2025-06-30): $132.0M
  • Q3 FY25 (2025-03-31): $151.0M
  • = $862.0M
CapEx
Prior FY + current-quarter YTD − same-quarter-prior-year YTD
  • FY FY25 (2025-06-30): +$407.0M
  • Q2 FY26 (2025-12-31) YTD: +$180.0M
  • Q2 FY25 (2024-12-31) YTD: −$157.0M
  • = $430.0M
Prior-year TTM revenue (growth-calc baseline)
Sum of the four most recent per-quarter values
  • Q2 FY25 (2024-12-31): $2.24B
  • Q1 FY25 (2024-09-30): $2.10B
  • Q4 FY24 (2024-06-30): $2.09B
  • Q3 FY24 (2024-03-31): $1.99B
  • = $8.42B

1 · Enterprise-value target (what the DCF must match)

Market cap   = price × diluted shares
             = $26.20 × 562.0M
             = $14.72B

EV target    = market cap + total debt − cash & equivalents
             = $14.72B + $2.92B − $2.05B
             = $15.60B
            

2 · Starting NOPAT (base year 0)

GAAP EBIT          = $862.0M   (10.0% of revenue)
× (1 − tax rate)  = × (1 − 35.2%) = × 0.6479
= NOPAT₀            = $558.5M
            

3 · Invested capital & starting ROIC

Invested capital = total debt + book equity − cash
                 = $2.92B + $8.79B − $2.05B
                 = $9.66B

Raw ROIC₀        = NOPAT₀ / Invested capital
                 = $558.5M / $9.66B
                 = 5.8%
(no cap applied; raw value is within the 40.0% ceiling)
            

4 · Growth path construction

Source       = analyst consensus (absolute forecast, TTM-anchored): Y1 = 2.1%, Y2 = 4.0%
Clamp        = [2.5%, 60%] (no sub-terminal or 60%+ starts)
Plateau rate = 4.0% (Y2 — held from year 2 through end of plateau)
Tier         = 3 years (rule: plateau rate < 15% → 3y, < 25% → 5y, else 7y)
Plateau      = 3 years
Fade         = linear from effective Y2 to terminal 2.5% across the remaining 7 years

Effective Y1 growth after solver bumps = 16.1%
Effective Y2 growth after solver bumps = 18.0%
Growth by year:
  Y1 = 16.1%
  Y2 = 18.0%
  Y3 = 18.0%
  Y4 = 15.8%
  Y5 = 13.6%
  Y6 = 11.4%
  Y7 = 9.1%
  Y8 = 6.9%
  Y9 = 4.7%
  Y10 = 2.5%
            

5 · Margin path construction

Starting margin (Y0) = 10.0%   (source: latest FY EBIT margin (GAAP))
Target margin (Y10)  = 80.0%   (solver output, widened band)
Year-t margin        = starting + (target − starting) × (t / 10)
Margin by year:
  Y1 = 17.0%
  Y2 = 24.0%
  Y3 = 31.0%
  Y4 = 38.0%
  Y5 = 45.0%
  Y6 = 52.0%
  Y7 = 59.0%
  Y8 = 66.0%
  Y9 = 73.0%
  Y10 = 80.0%
            

6 · ROIC path construction

The capex heuristic compares latest-period CapEx ($430.0M) against the Normalized CapEx (3-yr mean) of $370.3M — mean of the last three annual CapEx values. When the latest is above 1.4× that mean and CapEx is at least 5% of revenue, we treat the filer as capital-intensive and mid-investment, hold ROIC flat for a 5-year harvest phase, and only then fade to terminal ROIC. The 3-yr mean does not feed the DCF directly — it only gates this flag.

Capex-heuristic inactive (latest CapEx 1.16× the 3-yr mean of $370.3M — below the 1.4× / 5%-of-revenue gates).
Fade from Y1: ROIC_t = ROIC₀ + (ROIC_terminal − ROIC₀) × (t / 10)
ROIC₀ = 5.8%; ROIC_terminal = 11.0%

ROIC by year:
  Y1 = 6.3%
  Y2 = 6.8%
  Y3 = 7.3%
  Y4 = 7.9%
  Y5 = 8.4%
  Y6 = 8.9%
  Y7 = 9.4%
  Y8 = 10.0%
  Y9 = 10.5%
  Y10 = 11.0%
            

7 · Solver iterations

Each row is one bisection attempt. The solver sweeps Y1 growth bumps 0pp → +20pp across the plateau ladder inside the normal margin bracket, then — if nothing reconciles — repeats the same sweep in a widened margin band ([-10%, 80%]). The first feasible attempt is the one the page uses. If no combination reconciles, the page shows the attempt whose PV sits closest to the target EV so both levers are balanced.

# Phase Plateau Y1 bump Solved margin PV(EV) vs target Feasible?
1 normal 3y +0pp 12.6% $6.65B −57.4% no
2 normal 3y +2pp 12.6% $6.66B −57.3% no
3 normal 3y +4pp 12.6% $6.69B −57.1% no
4 normal 3y +6pp 12.6% $6.72B −56.9% no
5 normal 3y +8pp 12.6% $6.76B −56.6% no
6 normal 3y +10pp 12.6% $6.82B −56.2% no
7 normal 3y +12pp 12.6% $6.90B −55.8% no
8 normal 3y +14pp 12.6% $6.99B −55.2% no
9 normal 3y +16pp 12.6% $7.10B −54.5% no
10 normal 3y +18pp 12.6% $7.23B −53.6% no
11 normal 3y +20pp 12.6% $7.38B −52.7% no
12 normal 5y +0pp 12.6% $6.67B −57.3% no
13 normal 5y +2pp 12.6% $6.70B −57.0% no
14 normal 5y +4pp 12.6% $6.76B −56.7% no
15 normal 5y +6pp 12.6% $6.83B −56.2% no
16 normal 5y +8pp 12.6% $6.92B −55.7% no
17 normal 5y +10pp 12.6% $7.03B −54.9% no
18 normal 5y +12pp 12.6% $7.17B −54.0% no
19 normal 5y +14pp 12.6% $7.34B −52.9% no
20 normal 5y +16pp 12.6% $7.54B −51.7% no
21 normal 5y +18pp 12.6% $7.77B −50.2% no
22 normal 5y +20pp 12.6% $8.05B −48.4% no
23 widened 3y +0pp 80.0% $9.20B −41.0% no
24 widened 3y +2pp 80.0% $9.79B −37.2% no
25 widened 3y +4pp 80.0% $10.47B −32.9% no
26 widened 3y +6pp 80.0% $11.24B −27.9% no
27 widened 3y +8pp 80.0% $12.12B −22.3% no
28 widened 3y +10pp 80.0% $13.11B −15.9% no
29 widened 3y +12pp 80.0% $14.23B −8.8% no
30 widened 3y +14pp 80.0% $15.48B −0.8% yes ✓

8 · Terminal value derivation

NOPAT_{N+1}         = NOPAT_{10} × (1 + g_terminal)
                    = $13.26B × (1 + 2.5%)
                    = $13.59B

ΔNOPAT              = NOPAT_{N+1} − NOPAT_{10}
                    = $331.5M
Reinvestment_{N+1}  = ΔNOPAT / ROIC_terminal
                    = $331.5M / 11.0%
                    = $3.01B

FCF_{N+1}           = NOPAT_{N+1} − Reinvestment_{N+1}
                    = $13.59B − $3.01B
                    = $10.58B

Terminal value (TV) = FCF_{N+1} / (WACC − g_terminal)
                    = $10.58B / (9.0% − 2.5%)
                    = $162.74B

PV(TV)              = TV / (1 + WACC)^10
                    = $162.74B / 2.367
                    = $68.74B
            

9 · Reconciliation check (DCF PV vs. the market)

This isn't a fair value — it's the inverse check. The solver built the scenario so that DCF PV reproduces the current enterprise value; if the normal bracket worked the delta below is ~0 by construction. A non-zero delta only appears when the solver fell through to the widened margin band.

Σ PV(FCF_1..10) = -$53.26B
+ PV(TV)          = $68.74B
= Enterprise value = $15.48B   (widened solve — may differ from EV target)
− Total debt      = $2.92B
+ Cash            = $2.05B
= Equity value    = $14.61B
÷ Diluted shares  = 562.0M
= DCF PV / share  = $25.99

Market price      = $26.20
Reconciliation Δ  = −0.8%   (widened band — residual gap the scenario could not close)
            
Open this scenario in the calculator →
Every input above is pre-filled; the calculator auto-runs and lets you override any assumption.

Every rule above — growth-source priority, plateau tiers, compound cap, solver ladder, flag colours — is documented on the expectations scenario methodology.

What these ratios mean & how they're built: see the valuation ratios glossary on the company-facts methodology page — per-ratio definitions and the exact us-gaap concepts behind each numerator and denominator.

Sources. Denominators come from SEC EDGAR XBRL filings for NWSA (CIK 0001564708); analyst growth forecasts come from analyst consensus. Share price is the latest split-adjusted close from our daily history (live quote as fallback). Per-share denominators are split-adjusted to today's share count.